/
World Kidney Day 2016:  Kidney Disease & Children. Act Early to Prevent It World Kidney Day 2016:  Kidney Disease & Children. Act Early to Prevent It

World Kidney Day 2016: Kidney Disease & Children. Act Early to Prevent It - PowerPoint Presentation

eliza
eliza . @eliza
Follow
343 views
Uploaded On 2022-06-15

World Kidney Day 2016: Kidney Disease & Children. Act Early to Prevent It - PPT Presentation

Kidney disease affects millions of people worldwide including many children who may be at risk at an early age It is therefore crucial that we encourage and facilitate education early detection and a healthy life style in children to fight the increase of preventable kidney diseases and ID: 918564

disease kidney agents children kidney disease children agents background streptococcal early iga nephropathy hematuria glomerular due normal acute systemic

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "World Kidney Day 2016: Kidney Disease &..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

World Kidney Day 2016:

Kidney Disease & Children. Act Early to Prevent It

!

Slide2

Kidney disease affects millions of people worldwide, including many children who may be at risk at an early age. It is therefore crucial that we encourage and facilitate education, early detection and a healthy life style in children, to fight the increase of preventable kidney diseases and to treat children with inborn and acquired disorders of the kidneys worldwide

.

World Kidney Day 2016:

Kidney Disease & Children. Act Early to Prevent It!

Slide3

Pediatric Kidney Disease – An Update

Edited by the ASPN Clinical Affairs Committee

Slide4

Glomerulonephritis (GN)

Juan

Kupferman

, MD

Albert Einstein School of Medicine

Slide5

GN: Background

GN is an important cause of morbidity and mortality in patients of all ages

GN is characterized by glomerular injury and inflammation

GN is defined by the presence of some or all of these

clinico

-biochemical characteristics

Hematuria (always present)

Proteinuria

Edema

Hypertension

Most cases are due to an immunologic response to a variety of etiologic agents

Normal glomerulus

Acute glomerulonephritis

Slide6

GN has multiple etiologies and could be primary (affecting only the kidneys) or secondary to a systemic diseaseMost common:

Post-Streptococcal GN (PSGN)

IgA nephropathy (

IgAN

)

Henoch-Schonlein purpura (HSP)

Systemic lupus

erythematosis

(SLE)

GN: Background

Slide7

Acute post-Streptococcal GN is the most common glomerulonephritis in childhoodTypically with low complement C3 and evidence of recent

Streptococcal

infectionOther microorganisms can cause similar

findings

IgA nephropathy typically presents with recurrent episodes of gross hematuria

Complement is normal

GN: Background

Normal capillary loop (EM)

Post-Streptococcal GN (EM)

Slide8

Henoch-Schonlein purpura nephritis occurs during or after resolution of the acute diseaseSimilar renal histologic findings to IgA nephropathy

Systemic lupus erythematosus can cause focal to diffuse proliferative kidney disease

ANA is positive and

complements C3 and C4

may be decreased

GN: Background

Slide9

Specific therapy depends on etiologyTreatment goals Reduce glomerular inflammationInduce and maintain remission of proteinuria

Improve kidney function, if decreased

Control complications due to fluid retention (

i.e.

hypertension, edema)

Therapeutic agents includeAntiproteinuric agents (ACE inhibitors or ARBs)

Fish oil (in IgA nephropathy)

Steroids

Immunosuppresive

agents

Cyclophosphamide

Mycophenolate

mofetilRituximabPlasmapheresisGN: Treatment

Slide10

Hematuria could be a risk factor for chronic kidney disease progression in glomerular diseases -Moreno et al. Hematuria. Pediatr Nephrol 2015

Urine biomarkers, such as monocyte chemoattractant protein-1/CCL2 and neutrophil gelatinase-associated

lipocalin

, may be useful tools in the assessment of disease activity in lupus nephritis

-

Abulaban et al. Biomarkers. Curr

Rheumatol

Rep 2015

GN: New developments

Slide11

Characterized by glomerular injury and inflammation, often due to an immunologic response to a variety of etiologic agents

There are a variety of immunomodulator therapies that must be tailored to the specific etiology

Novel biomarkers and medications are being developed to enhance our ability to diagnose, predict prognosis, and treat

.

GN: Summary

Slide12

Your pediatric nephrology community continues to work hard to improve clinical care, foster education, and advance the science regarding kidney disease in children! We appreciate your support and all you do for children’s health care!

Happy World Kidney Day 2016!